Literature DB >> 19054023

An unusual presentation of an anomalous left coronary artery arising from the pulmonary artery (ALCAPA) in an adult: anterior papillary muscle rupture causing severe mitral regurgitation.

Louis Hofmeyr1, Johannes Moolman, Edmund Brice, Helmuth Weich.   

Abstract

We describe a 29-year-old male, previously in good health, with no history of angina pectoris and no risk factors for ischemic heart disease presenting with biventricular failure and severe mitral valve regurgitation. There were no signs or serological test results to suggest infective endocarditis. Transthoracic echocardiography (TTE) revealed severe anterior mitral valve prolapse secondary to papillary muscle rupture, severe mitral valve regurgitation, as well as an anterior myocardial wall hypokinesis. Parasternal short-axis view showed an anomalous left coronary artery arising from the pulmonary artery (ALCAPA), which was confirmed on coronary angiography. This is an unusual presentation of ALCAPA in an adult.

Entities:  

Mesh:

Year:  2008        PMID: 19054023     DOI: 10.1111/j.1540-8175.2008.00815.x

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  3 in total

1.  Anomalous origin of the left coronary artery from the pulmonary artery as a rare cause of mitral valve prolapse: a case report.

Authors:  Xuefeng Wang; Xiaorong Xia; Weiyi Huang; Xin Li; Yingcai Liu
Journal:  BMC Cardiovasc Disord       Date:  2022-07-04       Impact factor: 2.174

2.  Image Diagnosis: An Anomalous Origin of Left Coronary Artery from the Pulmonary Artery.

Authors:  Haisong Bu; Tianli Zhao
Journal:  Arq Bras Cardiol       Date:  2020-05-18       Impact factor: 2.000

3.  Late presentation of an anomalous left coronary artery from the pulmonary artery treated with conservative surgical management with long-term cardiac magnetic resonance imaging follow-up.

Authors:  Pishoy Gouda; John Gouda; Craig Butler; Robert C Welsh
Journal:  SAGE Open Med Case Rep       Date:  2017-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.